The Delaware Court of Chancery, in In re Metlife, Inc. Derivative Litigation, C.A. No. 2019-0452-SG (consol.), memo. op. (Del. Ch. Aug. 17, 2020), dismisses Caremark claims, finding no substantial likelihood of director liability for bad-faith breach of the fiduciary oversight duty based on an alleged failure to adopt modern practices in one business segment following regulatory action affecting an analogous segment.

Morris James discusses the decision in Chancery Dismisses Caremark Claims Against Metlife Board.